CGS 15943 (Synonyms: CGS 15943A) |
| Catalog No.GC10070 |
adenosine receptor antagonist
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 104615-18-1
Sample solution is provided at 25 µL, 10mM.
GlpBio Products Cited In Reputable Papers
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Product Documents
Quality Control & SDS
- View current batch:
- Purity: >99.50%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
| Cas No. | 104615-18-1 | SDF | |
| Synonyms | CGS 15943A | ||
| Chemical Name | 9-chloro-2-(furan-2-yl)-[1,2,4]triazolo[1,5-c]quinazolin-5-amine | ||
| Canonical SMILES | ClC1=CC=C2N=C(N)N3N=C(C4=CC=CO4)N=C3C2=C1 | ||
| Formula | C13H8ClN5O | M.Wt | 285.69 |
| Solubility | DMF: 1 mg/ml,DMF:PBS (pH 7.2)(1:3): 0.25 mg/ml,DMSO: 0.5 mg/ml | Storage | Store at RT |
| General tips | Please select the appropriate solvent to prepare the stock solution according to the
solubility of the product in different solvents; once the solution is prepared, please store it in
separate packages to avoid product failure caused by repeated freezing and thawing.Storage method
and period of the stock solution: When stored at -80°C, please use it within 6 months; when stored
at -20°C, please use it within 1 month. To increase solubility, heat the tube to 37°C and then oscillate in an ultrasonic bath for some time. |
||
| Shipping Condition | Evaluation sample solution: shipped with blue ice. All other sizes available: with RT, or with Blue Ice upon request. | ||
Complete Stock Solution Preparation Table
| Prepare stock solution | |||
|
1 mg | 5 mg | 10 mg |
| 1 mM | 3.5003 mL | 17.5015 mL | 35.003 mL |
| 5 mM | 0.7001 mL | 3.5003 mL | 7.0006 mL |
| 10 mM | 0.35 mL | 1.7501 mL | 3.5003 mL |
In vivo Formulation Calculator (Clear solution)
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
g
μL
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such as vortex, ultrasound or hot water bath can be used to aid dissolving.
3. All of the above co-solvents are available for purchase on the GlpBio website.
Related Products
- GC30206 Roluperidone (CYR-101)
- GC42309 3-p-FBT (hydrochloride)
- GC43111 C8 L-threo Ceramide (d18:1/8:0)
- GC61188 PIP-199
- GC14083 MDL 72222
- GC10978 Terfenadine
- GC38338 Bis-PEG1-NHS ester
- GC60005 (S)-3-(4-Hydroxyphenyl)-2-hydroxypropionic acid
- GC18083 CP 99994 dihydrochloride
- GC39709 Fmoc-amino-PEG3-CH2COOH
- GC10531 AGI-5198
- GC60224 L-Glyceric acid
- GC41483 5-hydroxy Propranolol
- GC30017 Tyloxapol (Triton WR1339)
- GC34829 Tau protein (592-597), Human TFA
- GC35123 3X FLAG peptide TFA
- GC34235 HIV-1 TAT 48-60
Reviews
Average Rating: 5 ★★★★★ (Based on Reviews and 13 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *